Post-nephrectomy prognostic score for non-metastatic RCC: pathologic T/N stage, tumor size (cm), ISUP/Fuhrman nuclear grade, and histologic necrosis. Risk groups: low 0–2, intermediate 3–5, high ≥6 points. Reports estimated metastasis-free and cancer-specific survival at 1–10 years.

Oncology · Updated 4/13/2026

Symptom score for lower urinary tract symptoms.

Symptom Scores · Updated 4/13/2026

Post-nephrectomy RCC adverse-feature index (educational; not full nomogram).

Oncology · Updated 4/13/2026

Historical grading aid for clear-cell RCC pathology (grade 1-4).

Oncology · Updated 4/13/2026

Counts 6 adverse prognostic factors to classify favorable/intermediate/poor metastatic RCC risk.

Oncology · Updated 4/13/2026

Guideline-style checklist for cT1a small renal mass management pathways.

Oncology · Updated 4/13/2026

Metastatic RCC prognosis by adverse risk factors count.

Oncology · Updated 4/13/2026

Post-nephrectomy RCC recurrence feature checklist (educational proxy).

Oncology · Updated 4/13/2026

Tumor volume normalized to prostate volume.

General Calculators · Updated 4/13/2026

PSA doubling-time estimate from serial PSA values.

General Calculators · Updated 4/13/2026

Checklist-style support for localized renal mass pathway discussions.

Oncology · Updated 4/13/2026

Anatomical complexity scoring for renal masses (R,E,N,A,L components).

Oncology · Updated 4/13/2026

Symptom severity score for urinary incontinence.

Disease Activity · Updated 4/13/2026

Simplified Stage-Size-Grade-Necrosis adverse feature scoring for RCC.

Oncology · Updated 4/13/2026

CT-based S.T.O.N.E. sum for percutaneous nephrolithotomy complexity and stone-free expectations.

Surgical Risk / Staging · Updated 4/13/2026

Clinical prediction score aid for uncomplicated ureteral stone.

Emergency · Updated 4/13/2026

Simplified RCC risk grouping from stage, grade, and ECOG.

Oncology · Updated 4/13/2026